Participants list

ACCINOV

A 6,500 sq. m real estate program located in the heart of Lyon Gerland, France, providing biological analysis and biomanufacturing services, run by 5MBs. 3 biomanufacturing platforms & 24 bioanalysis laboratories compliant to GLP & GMP standards supplied with a fully integrated service offer to ensure facilities management and regulatory compliance. A competitive structure for new biotech companies providing an innovative system based on shared resources, facilities and equipment.

More

AFFILOGIC

Affilogic develops custom affinity ligands for bioprocessing, analytics, diagnostics & therapeutic applications. Affilogic ligands, a.k.a. Nanofitins, are highly stable, easy to manufacture and perform like mAbs in selected applications.

The company is providing custom development of specific Nanofitins and is looking for partners to co-develop applications in Point of Care.

More

ALAXIA

Alaxia, a drug discovery company, develops airway therapeutic solutions for respiratory diseases based on its own peroxidase plate form. Its Meveol product, 1^st product exiting the pipeline, has been recognized Orphan medicinal product for cystic fibrosis condition by both EMA & FDA. Meveol is both an antimicrobial and anti-inflammatory product, targeting to kills bacteria, including antibiotic resistant strains and to compensate innate lung defense system.

More

ALGENICS

ALGENICS is a biopharmaceutical company leveraging a unique microalgae-based technology to produce recombinant therapeutics for animal and human health.

Microalgal cell lines engineered using our platform Algebiosys^TM are available under licensing agreement for production of glycosylated therapeutics with preferential applications in the field of monoclonal antibodies and viral subunits. Our strategy is also to develop proprietary biotherapeutics for human use benefiting from our technology. Targets include recombinant products with enhanced biological activities for applications in oncology and virology.

More

ALIZE PHARMA

The Alizé Pharma Group is specialized in the development of innovative biopharmaceuticals for the treatment of metabolic diseases and cancer. Its management is made up of a team of drug development experts and a board of directors offering wide international experience. The two main products currently in development include a ghrelin-derived peptide targeting type II diabetes and other cardiovascular risks, and a PEGylated recombinant L-asparaginase for the treatment of acute lymphoblastic leukemia.

More

ALSACE BIO VALLEY

Alsace BioValley, one of the world-class French Health Competitiveness Clusters, represents an ideal gateway to develop any bio-business on a European scale in an efficient and swift manner : help to setting up (location, infrastructures...), finding partners and technologies, identifying financing opportunities, business connections & matching, business & networking events. Alsace BioValley is also the French coordinator of BioValley, the trinational cluster involved in life sciences which sweeps away the boundaries of France, Germany and Switzerland, a genuine force serving a successful opening towards Europe and the world.

More

ALSACE INTERNATIONAL

Alsace International is the economic development agency of the Alsace region. We accompany international companies interested in doing business in ALSACE's BIOVALLEY, the leading trinational life sciences cluster in Europe

Alsace International provides free and confidential customized services for companies interested in knowing more about doing business in Alsace or in Europe. Services include location information, grant negotiations, access to venture capital, business and scientific contact facilitator, staff integration. AI works in close collaboration with the ABV network of regional partners.

More

ALZPROTECT

Alzprotect is a startup biopharmaceutical company developing small molecule drug for neurodegenerative diseases. Its lead product, AZP2006, an anti Alzheimer candidate drug, will enter clinical phase 1 by the end of 2012. Animal proof of concept studies have shown its unique effect on both APP and Tau pathologies. Alzprotect is developing in parallel several small molecules against neurodegenerative diseases

More

AMATSI

AMATSI group, located at Montpellier, Toulouse and Idron in France and Cambridge in the USA, is a Contract Development and Manufacturing Organization (CDMO) specialized in Drug Development services. With its strong team of 190 staff, AMATSI group (formerly CRID PHARMA, AVOGADRO and DBI) offers customized Pharmaceutical Development and Clinical Supplies management services to Biotech and Pharmaceutical companies. Range of expertise: Formulation & analytical development, PK-ADME studies, bioanalysis, Quality Control, Clinical supplies manufacturing, packaging, storage and logistics, ICH Stability study.

More

ANIMASCOPE

Preclinical imaging studies are great interest for the development of new pharmaceuticals through the use of a broad range of existing methodologies and the development of new diagnostic and therapeutic options for the management of pathologies. In biomedical research, non-invasive in vivo imaging is applicable to exploratory research and bridges the gap between preclinical and clinical research. In R&D, imaging is particularly useful for pathophysiology, drug efficacy evaluation and model validation studies. In vivo imaging techniques are non-invasive and can therefore be used to perform longitudinal and dynamic studies. Indeed, the use of these tools minimizes the intra- and interspecies experimental variability, greatly reduces the need for an elevated number of animals, and curtails the time to perform a given experiment. Non-invasive in vivo imaging is a cost and time-effective approach to streamline R&D and increase predictability of clinical outcomes.

More

ANS BIOTECH

ANS Biotech, a preclinical CRO dedicated to pain pharmacology, supports drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with:

• Clinically relevant in vivo models for successful R&D of innovative analgesics, especially in  the field of inflammatory pain, postoperative pain, neuropathic pain and visceral pain ;
• Customized scientific studies meeting drug discovery and development objectives ;
• Consulting activities.

More

APTYS PHARMACEUTICALS

Aptys Pharmaceuticals is a Drug Delivery and Formulation Company which was founded in 2002 after the acquisition of drug delivery patents from the University of Clermont-Ferrand (France). Since then, Aptys has developed several patent based products for its customers as well as on its own. One of these products, a new transdermal formulation of testosterone is now in phase III in the US. Aptys is seeking a partner to launch the product on the US market.

More

ARDE AUVERGNE

The Regional Economic Development Agency for Auvergne objective is to structure and promote the region's talents in biotechnologies. One main mission: to canvass successful companies in a position to develop investment projects in Auvergne and to help them set up in the region.

More

ARIANA PHARMACEUTICALS

Ariana offers a unique technology that accurately identifies the best patient responder sub-groups in clinical trials, and optimizes biomarker/diagnostic signatures.  Ariana applies its proprietary "rules-based" data analytical approach - KEM® - to clinical datasets to identify complex relations that all other approaches miss, thus enabling decision-makers to optimize all possible endpoints simultaneously. Ariana's world-class team of experienced, inter-disciplinary scientists includes PhD biologists, computer scientists, biostatisticians, bio-informatics specialists, chemists and clinical experts.  Ariana was founded in 2003 as a spin-out from the Institut Pasteur, and has offices in Paris, France and Cambridge, Mass, USA.

More

ASSISTANCE PUBLIQUE – HOPITAUX DE PARIS

AP-HP is a public health federation for the Paris metropolitan area that gathers 38 hospitals and employs more than 90 000 persons. AP-HP holds a pipeline of almost 400 active patents in various fields: drug discovery, medical device, gene and cell therapies, genetics and diagnostics. Through its Office of Technology transfer and Industrial Partnerships (OTT&PI), AP-HP has successfully developed an active policy of technology transfer and valuation of the innovations stemming from its medical and research teams.

More

ATLANPOLE BIOTHERAPIES

Atlanpole Biotherapies gives you access to extended skills, from biodiagnostics to biomedicine in 3 major areas: immunobiotherapies, radiopharmaceuticals and regenerative medicine. For pharmaceutical companies looking for high level partners devoted to healthcare and biotech, Atlanpole Biotherapies is a cluster that draws together a community of innovative companies, fundamental & clinical research organizations and higher education institutions, all located in Western France.

More

BIO MODELING SYSTEMS

BMSYSTEMS :THE  HEURISTIC SYSTEMS BIOLOGY COMPANY

BMSYSTEMS is the first and to date the only Integrative Systems Biology Company that succeeded to create in-silico heuristic models validated in-vivo. These CADI*^TM outputs led to discoveries, patents, or operational businesses through its innovative business model, in the fields of infectious diseases, neurology, psychiatry, oncology and industrial biotech.          

More

BIOFILM CONTROL

Our proprietary technology forms the basis for several alerting, diagnostics and theranostics tests currently under retrospective clinical validation:  1) Antibiofilmogram ® and bacterial virulence tests: improved antibiotic prescription and treatment orientation tests based on the surface invasion and biofilm formation profiles of infecting bacteria. 2) Hidden infections and biomarkers diagnostics based on homogeneous and label free immuno-detection in blood, saliva and urine with direct visual readout or with (portable) imaging devices.

More

BIOFIT EVENT

BioFIT (Fostering Innovation & Transfer), the only international partnering event in the field of technology transfer and collaborative projects in the life sciences sector, will be held in Lille, France on 3rd and 4th December 2012, after a first successful edition in 2010.

Academics, industry stakeholders and entrepreneurs, together with practitioners in technology transfer, intellectual property and licensing will share best practices, know-how and will maximize qualified alliances thanks to a cutting-edge partnering platform.

More

BIOPOLE CLERMONT-LIMAGNE

The Biopôle Clermont-Limagne was one of the first European technology parks fully dedicated to hosting and supporting bio-tech businesses.

It offers bio entrepreneurs an extensive range of tools aimed at enhancing business creation and development: creation support, networks and funding, accommodation and services.

The Biopôle Clermont-Limagne is an interactive platform for professionals of the life sciences sector. It encourages collaborative networking between companies, research centers, professional associations, sciences parks and economic development organizations.

More